mechanism of glp-1 receptor agonists Frontiers Advances in GLP-1 receptor agonists:

So far, clinical trials havent resulted in regulatory approval, and pharmaceutical companies havent been motivated to invest in further development

Add 1,000 L (1 mL) of reconstitution solvent to the 1 mg vial This yields a 1 mg/mL (1,000 g/mL) stock solution To achieve 100 g/mL working stock: Dilute 100 L of 1 mg/mL stock into 900 L of PBS or cell culture medium yields 100 g/mL in 1 mL To achieve 10 ng/mL in a 5 mL experiment: Take 0.5 L of 100 g/mL working stock + 4,999.5 L of medium Alternatively: dilute to an intermediate concentration to reduce pipetting error Use a dilution series approach (stock working stock final experimental concentration) to minimize pipetting inaccuracy at nanogram-level concentrations

T., Kim, K

10.1111/j.1365-2125.2011.04086.x Br

Just need fluids

doi: 10.3390/healthcare8030211 40 WilliamsLRIsaacson-BarashC